...
首页> 外文期刊>RSC Advances >Revealing biomedically relevant cell and lectin type-dependent structure-activity profiles for glycoclusters by using tissue sections as an assay platform
【24h】

Revealing biomedically relevant cell and lectin type-dependent structure-activity profiles for glycoclusters by using tissue sections as an assay platform

机译:通过使用组织部分作为测定平台,揭示生物学相关的细胞和凝集素依赖性结构 - 活性曲线的糖蛋白酶

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The increasing realization of the involvement of lectin-glycan recognition in (patho)physiological processes inspires envisioning therapeutic intervention by high-avidity/specificity blocking reagents. Synthetic glycoclusters are proving to have potential for becoming such inhibitors but the commonly used assays have their drawbacks to predict in vivo efficacy. They do not represent the natural complexity of (i) cell types and (ii) spatial and structural complexity of glycoconjugate representation. Moreover, testing lectins in mixtures, as present in situ, remains a major challenge, giving direction to this work. Using a toolbox with four lectins and six bi- to tetravalent glycoclusters bearing the cognate sugar in a model study, we here document the efficient and versatile application of tissue sections (from murine jejunum as the model) as a platform for routine and systematic glycocluster testing without commonly encountered limitations. The nature of glycocluster structure, especially core and valency, and of protein features, i.e. architecture, fine-specificity and valency, are shown to have an influence, as cell types can differ in response profiles. Proceeding from light microscopy to monitoring by fluorescence microscopy enables grading of glycocluster activity on individual lectins tested in mixtures. This work provides a robust tool for testing glycoclusters prior to considering in vivo experiments.
机译:增加了凝集素 - 聚糖识别(Patho)生理过程中的参与的实现激发了通过高亲和力/特异性阻断试剂的设想治疗干预。合成糖蛋白被证明具有成为这种抑制剂的可能性,但常用的测定具有其缺点以预测体内疗效。它们不代表(i)细胞类型的自然复杂性和(ii)糖缀合物表示的空间和结构复杂性。此外,如原位目前的混合物中的凝集素仍然是一个重大挑战,给出了这项工作的方向。使用具有四章凝集素的工具箱和六种血管糖蛋白在模型研究中的同源糖,我们在这里记载了组织切片(从鼠JEJUNUM作为模型)作为常规和系统糖粉测试的平台的高效和多功能地应用没有常见的限制。糖晶板结构的性质,尤其是核心和价值,蛋白质特征,即架构,细特异性和价值,被认为具有影响,因为细胞类型可以在响应型材中不同。从光学显微镜进行以通过荧光显微镜进行监测,使得在混合物中测试的个体凝集素上的糖粉活性进行分级。这项工作提供了一种强大的工具,用于在考虑体内实验之前测试Glycoclusters。

著录项

  • 来源
    《RSC Advances》 |2018年第50期|共20页
  • 作者单位

    Ludwig Maximilians Univ Munchen Inst Physiol Chem Fac Vet Med Vet Str 13 D-80539 Munich Germany;

    Ludwig Maximilians Univ Munchen Inst Physiol Chem Fac Vet Med Vet Str 13 D-80539 Munich Germany;

    Ludwig Maximilians Univ Munchen Inst Physiol Chem Fac Vet Med Vet Str 13 D-80539 Munich Germany;

    Natl Univ Ireland Gahvay Sch Chem Univ Rd Galway Ireland;

    Natl Univ Ireland Gahvay Sch Chem Univ Rd Galway Ireland;

    Natl Univ Ireland Gahvay Sch Chem Univ Rd Galway Ireland;

    Ludwig Maximilians Univ Munchen Fac Vet Med Inst Anat Histol &

    Embryol Vet Str 13 D-80539 Munich Germany;

    RCSI Dept Chem 123 St Stephens Green Dublin 2 Ireland;

    RCSI Dept Chem 123 St Stephens Green Dublin 2 Ireland;

    RCSI Dept Chem 123 St Stephens Green Dublin 2 Ireland;

    Ludwig Maximilians Univ Munchen Inst Physiol Chem Fac Vet Med Vet Str 13 D-80539 Munich Germany;

    Natl Univ Ireland Gahvay Sch Chem Univ Rd Galway Ireland;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号